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Familial hypobetalipoproteinemia (FHBL) is an apparently autosomal dominant disorder of lipid metabolism char-
acterized by less than fifth percentile age- and sex-specific levels of apolipoprotein b (apob) and low-density lipo-
protein–cholesterol. In a minority of cases, FHBL is due to truncation-producing mutations in the apob gene on
chromosome 2p23-24. Previously, we reported on a four-generation FHBL kindred in which we had ruled out
linkage of the trait to the apob gene. To locate other loci containing genes for low apob levels in the kindred, a
genomewide search was conducted. Regions on 3p21.1-22 with two-point LOD scores 11.5 were identified. Ad-
ditional markers were typed in the region of these signals. Two-point LOD scores in the region of D3S2407 increased
to 3.35 at Ø = 0. GENEHUNTER confirmed this finding with an nonparametric multipoint LOD score of 7.5
( ). Additional model-free analyses were conducted with the square root of the apob level as the phenotype.P = .0004
Results from the Loki and SOLAR programs further confirmed linkage of FHBL to 3p21.1-22. Weaker linkage to
a region near D19S916 was also indicated by Loki and SOLAR. Thus, a heretofore unidentified genetic susceptibility
locus for FHBL may reside on chromosome 3.
Strong arguments may be made for studying the genetic
causes of low cholesterol. First, individuals with low
cholesterol levels live longer than do those with high
cholesterol levels (Anderson et al. 1987), and there is
good evidence that genetic factors are important in de-
termining low cholesterol levels (Hobbs et al. 1989;
Welty et al. 1998; Wu et al. 1999). Second, low choles-
terol levels may increase the risk for development of fatty
livers, at least in selected subjects (Tarugi et al. 1996;
Ahmed and Keefe 1998). By contrast, high cholesterol
is a well-established risk factor for atherosclerotic cor-
onary artery disease, along with high blood pressure,
diabetes mellitus, smoking, and a sedentary lifestyle (Ha-
vel and Kane 1995a, 1995b). Although genetic factors
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are important in determining both high and low cho-
lesterol levels, much more is known about the genetic
determinants of elevated plasma cholesterol concentra-
tions than about the factors that determine very low
cholesterol levels.
To identify “low cholesterol”–associated genes, we
have studied families with familial hypobetalipoprotei-
nemia (FHBL), a disorder of lipid metabolism defined
by less than fifth percentile age- and gender-specific levels
of apolipoprotein B (apob) (MIM 107730) and low-
density lipoprotein (LDL) cholesterol (Havel and Kane
1995a, 1995b; Schonfeld 1995). More than 35 different
truncation-specifying mutations of the apob gene (chro-
mosome 2p23-24) have been identified that cosegregate
with FHBL (Farese et al. 1992; Schonfeld 1995), and
the syndrome has been reproduced in mice. Nevertheless,
the genetic etiology of FHBL in the overwhelming ma-
jority of kindreds is not well understood (Welty et al.
1998; Wu et al. 1999). Fazio et al. (1991) and Pulai et
al. (1998) have reported on two FHBL kindreds in which
the trait is not linked to the apob gene. This suggested
that hitherto unreported susceptibility gene(s) might be
responsible for the low apob levels in these kindreds.
We now report on a genomewide search undertaken
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Figure 1 FHBL kindred, showing haplotypes consisting of eight markers on chromosome 3p. Solid symbols denote affected subjects.
Question marks denote borderline apob level. The magenta-colored bars represent the region segregating with affected FHBL subjects.
to find other susceptibility loci for FHBL in the family
reported by Pulai et al. (1998). Ascertainment of this
family occurred during screening of various St.
Louis–area volunteer populations for potential probands
with FHBL. Probands provided information on the
structures of their kindreds, members of which were then
invited to participate. The protocol was approved by the
Human Studies Committee (institutional review board)
of the Washington University Medical Center. Venous
blood plasmas were analyzed in the Core Laboratory
for Clinical Studies, which is Centers for Disease Control
standardized. Very-low-density-lipoprotein (VLDL),
LDL, and high-density lipoprotein (HDL) were isolated
by ultracentrifugation (Manual of Laboratory Opera-
tions 1982) and dextran sulfate precipitation, and their
triglyceride and cholesterol contents were assessed by
enzymatic methods. Total plasma apoA1 and apob were
determined by immunonephelometry (Contois et al.
1996).
Genomic DNA was extracted from peripheral blood
leukocytes by use of the Gentra Puregene DNA extrac-
tion kit. In the first round of genotyping, 387 markers
consisting of polymorphic tetra-, tri-, or dinucleotide
markers distributed over the genome at an average spac-
ing of 10 cM were typed at the Marshfield Medical Re-
search Foundation, Marshfield, WI, by use of screening
set 8. Additional markers around loci of interest were
subsequently typed. PCR amplifications and sizing of
alleles were carried out with standard procedures.
The FHBL family in this study consisted of 38 gen-
otyped individuals (fig. 1). For the initial analysis, ped-
igree members with less than fifth percentile age- and
sex-specific apob levels were considered affected. On the
basis of this criterion, 10 individuals were designated
affected. Individuals 401 and 405 in the fourth gener-
ation had borderline apob levels and were considered
unknown. The average apob level was 41 mg/dl (stan-
dard deviation 14) for the 10 affected individuals and
94 mg/dl (std = 32) for those unaffected. LDL cholesterol
(44 vs. 110 mg/dl) and total cholesterol levels (85 vs.
182 mg/dl) also were significantly lower in affected mem-
bers ( ). Mean ages and body mass indexesP ! .0001
(BMI) were not significantly different in affected and
unaffected subjects.
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Table 1
Summary of Results
CHROMOSOME
MAXIMUM SCORE (LOCATION) GIVEN BY
MLINK
LOD
GENEHUNTER
NPL Loki
SOLAR
LOD
3 3.3 (68 cM) 7.5 (68 cM) 2.0 (68 cM) 3.8 (68.5 cM)
19 1.7 (52 cM) 1.8 (16 cM) 2.0 (30 cM) 1.7 (30.0 cM)
20 1.8 (2 cM) 6.2 (0 cM) .5 (18 cM) .9 (25.0 cM)
Two-point LOD scores were computed for all markers
with the FASTLINK program (Cottingham et al. 1993),
under the assumption of an autosomal dominant mode
of transmission with reduced penetrance (75%) and a
gene frequency of .001. Genetic parameters were ob-
tained from segregation analysis with the computer pro-
gram Pedigree Analysis Package, or PAP (Hasstedt
1994). If a LOD score was 11.5, additional markers were
typed in the region of the signal, and updated two-point
LOD scores were computed. To avoid any potential un-
certainty in the exact mode of inheritance of FHBL, the
data were also analyzed with the model-free multipoint
allele-sharing method implemented in GENEHUNTER
(Kruglyak et al. 1996). We used linkage maps provided
by the Marshfield Medical Research Foundation’s Web
site. All marker allele frequencies were computed using
ILINK from the LINKAGE suite of programs (Lathrop
et al. 1984).
Dichotomizing a quantitative phenotype via a some-
what arbitrary cutoff can introduce an element of un-
certainty in the diagnostic classification and potentially
causes a loss of information in the analytic phase. Ac-
cordingly, additional investigations were performed with
the quantitative phenotype, using multipoint linkage
methods implemented in the computer programs Loki
(Heath 1996) and SOLAR (Almasy and Blangero 1998).
Age and gender were included as covariates in both anal-
yses. Loki, a promising newly proposed method for ol-
igogenic quantitative traits, permits joint analysis of
more than one chromosome at a time. It requires neither
an exact specification of the genetic model nor a des-
ignation of the exact number of quantitative trait loci
(QTLs) hypothesized to be in the model. Loki will jointly
estimate the number of QTLs affecting the trait and
perform linkage analysis. Although Loki does not pro-
vide traditional LOD scores, regions that have a high
probability of containing a QTL can be identified by
counting the number of QTLs placed within each cen-
timorgan of the genome and comparing this value to the
expected number under the hypothesis of no linkage.
The Loki score is defined to be the base 10 logarithm
of this ratio. Preliminary research has suggested that data
sets with Loki scores 12 generally produce LOD scores
13 (E. Wijsman, personal communication). Loki has suc-
cessfully identified two known genes in an Alzheimer
data set (Daw et al. 1999) and the trait genes in simu-
lated data (Heath 1996). The SOLAR computer package
conducts linkage analysis under the variance compo-
nents framework, providing LOD scores for extended
pedigrees. Multivariate normality of the trait is assumed.
We report two-point SOLAR LOD score results. By use
of the program Simwalk2, haplotypes were constructed
in those chromosomal regions giving the strongest signal
(Sobel and Lange 1996).
The initial genome scan resulted in two-point LOD
scores 11.5 at markers D3S1768 (Zmax = 2.3; ),v = 0
D19S433 (Zmax = 1.73; ), and D20S103 (Zmax=1.8;v = 0
). Additional markers were typed in the regions sur-v = 0
rounding these markers. Chromosome 3 markers pro-
vided the most significant increase, to Zmax = 3.28 (v =
), at the newly typed D3S2407. LOD scores did not0
increase for any of the additionally typed markers on
chromosomes 19 or 20 (table 1). Multipoint linkage
analysis with GENEHUNTER, using the dichotomous
phenotype, yielded a maximum nonparametric multi-
point LOD (NPL) score of 7.5 ( ) close toP ! .001
D3S2407 at 68 cM on our map. The maximum NPL
score for chromosomes 19 was 1.81 ( ) at 16 cM,P = .02
not consistent with the initial maximum LOD score of
1.73 at 52 cM on the sex-averaged map (at D19S433).
The chromosome 20 maximum NPL score of 6.2 (P !
) was at 0.0 cM, ∼4 cM from the location of the.005
maximum 2-point LOD score at marker D20S103.
For the Loki and SOLAR analyses, the phenotype was
defined to be the square root of the apob level, to reduce
kurtosis. To determine whether there were regions of
chromosome with evidence for quantitative trait loci
(QTL), we computed the Loki score jointly, using chro-
mosome 3, 19, and 20 markers. Because Loki is a Mar-
kov chain–Monte Carlo (MCMC) method, analyses
were repeated multiple times, each with different starting
values. We present results that are representative of all
Loki runs. Figure 2 displays a histogram of map position
versus Loki score for chromosome 3. Chromosome 3
showed strong support for linkage in the region of
D3S2407 at ∼68 cM on the Marshfield sex-averaged
map (table 1). The ratio of the observed to expected
number of QTLs was almost 100:1, or ∼2.0 on the base
10 logarithmic scale. If preliminary research on Loki
scores is correct, the LOD score would be 13.0. Chro-
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Figure 2 Histogram of map location versus Loki score for chromosome 3p. The Loki score is the logarithm10 of the ratio of observed
number of QTLs versus the expected number of QTLs in each centimorgan.
mosomes 19 and 20 analyses produced much broader
regions for the maximum Loki scores than did chro-
mosome 3 (data not shown). Evidence for linkage to
chromosome 19 was greatest at ∼30 cM, where the Loki
score was 0.84, or a ratio of observed to expected QTLS
of almost 7. Note that, on the basis of the dichotomous
phenotype, the two-point MLINK LOD scores were
!22 at markers D19S586 and D19S916, located at ∼31
cM (table 1). The maximum number of QTLs placed
on chromosome 20 was generally only two to three times
the expected number, producing Loki scores in the range
of 0.5, and the map position with the maximum number
of QTLs was less consistent than were those on chro-
mosome 3 and 19. Results from the two-point analysis
with SOLAR were most consistent with the chromosome
3 and 19 locations identified with Loki (table 1). The
maximum SOLAR LOD score of 3.8 was found on chro-
mosome 3 at D3S3597, located at 68.5 cM, ∼0.5 cM
from D3S2407. The maximum SOLAR LOD score for
chromosome 19 was 1.65 at marker D19S916, located
at ∼30 cM. The chromosome 20 maximum SOLAR
LOD score was 0.86 at 25 cM for marker D20S470.
Because of the low LOD scores obtained from Loki and
SOLAR, no further analyses were performed on chro-
mosome 20.
Haplotypes were constructed for the family with eight
markers spanning ∼12.7 cM on chromosome 3 (fig. 1).
A common haplotype between D3S3521 and D3S1578
was observed in all affected pedigree members. This hap-
lotype was also carried by the two brothers, subjects
205 and 206, in generation II and subject 402 in gen-
eration IV, none of whom was scored as affected. In-
dividual 205, a 74-year-old male, has an apob level of
79 mg/dl, (fifth percentile for his age and gender = 74
mg/dl). Individual 206 is a 60-year-old male with an
apob level of 87 mg/dl, placing him in the lower 25th
percentile for his age and sex. Subject 402 is a 14-year-
old female with apob level of 93 mg/dl (125th percen-
tile). There was a recombination in unaffected individual
314 (78 mg/dl; 125th percentile) between D3S3521 and
D3S2407, which suggests that the FHBL susceptibility
gene is located in the 3-cM region between D3S2407
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and D3S1578. A shared haplotype among all but one
affected subject was observed for chromosome 19 mark-
ers in an ∼11-cM sex-averaged region, 20.7–31.3 cM,
near the area producing the most significant quantitative
Loki and SOLAR scores. This haplotype, however, was
also shared by seven individuals with apob levels greater
than the fifth percentile for their age and sex.
Our analyses strongly suggest that chromosome 3 con-
tains a susceptibility region for FHBL in this kindred.
This was borne out not only by the positive LOD scores
obtained for the dichotomous phenotype but by analyses
in which apob level defined a quantitative phenotype.
Both the Loki and SOLAR programs identified the same
region to be harboring a FHBL trait locus. Haplotype
analysis supports that this susceptibility locus lies in the
3-cM region between D3S2407 and D3S1578. A region
on chromosome 19 was suggested in the two-point anal-
yses as a possible location for a FHBL gene; however,
the highest scores obtained by quantitative analyses were
not in the same area. Further data are required to either
confirm the chromosome 19 finding or identify it as a
false positive. An initial weak signal on chromosome 20
did not obtain support from analyses using the quan-
titative phenotype.
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